REFERENCES

-----(1996) "Assessment of sereological relatedness to of genital HPV by hemagglutination inhibition" Journal of Virology; 70:3298-3301.

(N Engl J Med 1997; 337 : 1343-9).

Medscape Women's Health 2(6), 1997. © 1997 Medscape, Inc.

Armstrong, BK et al (1986) "Time trends in the prevalence of cervical cytologic abnormalities in women attending an STD clinic and their relation to trends in sexual activity and HPV infections" British Journal of Cancer; 54:669-675.

Becker, TM et al. (1991) "Cervical papillomavirus infection and cervical dysplasia in Hispanic, Native American and non-Hispanic white women in New Mexico" American Journal of Public Health; 81:582-586.

Beutner, KR et al, "Human Papillomavirus and Human Disease." Am J Med 1997; 102(5A):9-15.

Bosch, FX et al. (1995) "Prevalence of HPV in cervical cancer: a worldwide perspective Journal of the National Cancer Inst; 87:796-802.

Fraiser, LD et al (1994) "HPV infections in children" Pediatric Annals; 23:354-360.

Galloway DA et al (1994) "HPV vaccines: a warty problem" Infectious Agents and Disease; 3:187-93.

Hildesheim A., Immune activation in cervical neoplasia: cross sectional association between plasma soluble interleukin 2 receptor levels and disease. Cancer-Epidemiol-Biomarkers-Prev. 1997 Oct; 6(10): 807-13.

Ho, G. et al. (1994) "Risk of genital HPV infection in women with HIV-induced immunosuppression" International J. Of Cancer; 56:788-792.

Ho-Gy et al. HPV 16 and cigarette smoking as risk factors for high grade cervical intra-epithelial neoplasia. Int-J-Cancer. 1998. Oct 29; 78 (3): 281-5

Int-J-Cancer : 78, 166-71 (1998)

Kataja, V. et al(1993) "Risk factors associated with cervical HPV infections: a case-control study" Am. Journal of Epidemiology; 138(9):735-45.

Koutsky, Laura et al. (1997) "Epidemiology of genital human papillomavirus infection" American Journal of Medicine; 102(5A):3-8.

Le Cann, P, et al (1994) "Self-assembly of HPV type 16 capsid proteins by expression of the L1 protein in insect cells" FEMS Microbiology Letters; 86:860-66.

Manolitsas-TP., Synchronous ovarian and cervical squamous intraepithelial neoplasia: an analysis of HPV status. Gynecol-Oncol. 1998 Sep; 70(3): 428-31.

Meberg R.. Characterization of plantar verrucae among individuals with human immunodeficiency virus. J-Am-Podiart-Med-Assoc. 1998 Sep; 88(9): 442-5

Nimako M., Human papillomavirus specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III. Cancer-Res. 1997 Nov 1; 57(21): 4855-61.

Roden, R. et al (1994) "Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins" Journal of Virology; 68:7570-7574.

Shiwen, P. et al (1998) "Papillomavirus VLPs can deliver defined CTL epitopes to the MHC class I pathway" Virology; 240: 147-57.

Tindle, R. et al (1998) "Vaccines against HPV" pps.767-778.from

Touze, A. et al (1998) "Production of recombinant virus like particles from HPV types 6, 11, 16, 45, by ELISA: implications for HPV prevention and detection" FEMS Microbiology Letters; 160:111-118.

Wang-Z et al. Human papillomavirus antivody responses among patients with incident cerical carcinoma. J-Med-Virol. 1997 Aug; 52 (4): 436-40.

White, W. et al (1998) "In vitro infection and type-restricted antibody-mediated neutralization of authentic HPV type 16" Journal of Virology; 72:959-964.